S
Soleno Therapeutics
SLNO
49.320
USD
0.87
(1.80%)
مفتوح الان
حجم التداول
3,149
الربح لكل سهم
0
العائد الربحي
0
P/E
-30
حجم السوق
2,113,448,566
الأخبار
العنوان: Soleno Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet forthe treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.